Extracorporeal photopheresis increases neutrophilic myeloid-derived suppressor cells in patients with GvHD

Bone Marrow Transplantation

Volumn 49, Issue 4, 2014, Pages 545-552

  Rieber, N ^a   Wecker, I ^a   Neri, D ^a   Fuchs, K ^a   Schafer I ^a   Brand, A ^a   Pfeiffer, M ^a   Lang, P ^a   Bethge, W ^a   Amon, O ^a   Handgretinger, R ^a   Hartl, D ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

ECP; GvHD; MDSC; Myeloid derived suppressor cells; Photopheresis

Indexed keywords

AMSACRINE; ARGINASE; BUSULFAN; CLOFARABINE; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOKINE; ETOPOSIDE; FLUDARABINE; INFLIXIMAB; MELPHALAN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS; THIOTEPA; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; APLASTIC ANEMIA; ARTICLE; BETA THALASSEMIA; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CHILD; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HUMAN; INNATE IMMUNITY; LEUKAPHERESIS; LYMPHOCYTE PROLIFERATION; MALE; MYELODYSPLASTIC SYNDROME; MYELOID PROGENITOR CELL; MYELOPROLIFERATIVE NEOPLASM; NEUTROPHIL; PRIORITY JOURNAL; PUVA; SUPPRESSOR CELL; T LYMPHOCYTE; TH1 CELL; TH17 CELL; ADOLESCENT; AGE; BLOOD; CASE CONTROL STUDY; CELL CULTURE; CHRONIC DISEASE; GRAFT VS HOST DISEASE; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CASE-CONTROL STUDIES; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; GRAFT VS HOST DISEASE; HUMANS; MALE; MIDDLE AGED; MYELOID CELLS; NEUTROPHILS; PHOTOPHERESIS; YOUNG ADULT;

EID: 84897486250     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2013.236     Document Type: Article

References (43)

1. Edelson R, Berger C, Gasparro F, Jegasothy B, Heald P, Wintroub B et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy - preliminary-results. New Engl J Med 1987; 316: 297-303.
2. Hautmann AH, Wolff D, Hahn J, Edinger M, Schirmer N, Ammer J et al. Extracorporeal photopheresis in 62 patients with acute and chronic GVHD: results of treatment with the COBE Spectra System. Bone Marrow Transplant 2013; 48: 439-445.
3. Flowers ME, Apperley JF, van Besien K, Elmaagacli A, Grigg A, Reddy V et al. A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. Blood 2008; 112: 2667-2674.
4. Seaton ED, Szydlo RM, Kanfer E, Apperley JF, Russell-Jones R. Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response. Blood 2003; 102: 1217-1223.
5. Knobler R, Barr ML, Couriel DR, Ferrara JL, French LE, Jaksch P et al. Extracorporeal photopheresis: past, present, and future. J Am Acad Dermatol 2009; 61: 652-665.
6. Bladon J, Taylor PC. Extracorporeal photopheresis: a focus on apoptosis and cytokines. J Dermatol Sci 2006; 43: 85-94.
7. Gatza E, Rogers CE, Clouthier SG, Lowler KP, Tawara I, Liu C et al. Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells. Blood 2008; 112: 1515-1521.
8. George JF, Gooden CW, Guo L, Kirklin JK. Role for CD4(+)CD25(+) T cells in inhibition of graft rejection by extracorporeal photopheresis. J Heart Lung Transplant 2008; 27: 616-622.
9. Meloni F, Cascina A, Miserere S, Perotti C, Vitulo P, Fietta AM. Peripheral CD4(+)CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients. Transplant Proc 2007; 39: 213-217.
10. Schmitt S, Johnson T, Karakhanova S, Naher H, Mahnke K, Enk A. Extracorporeal photopheresis augments the number and increases the function of regulatory T cells by triggering Adenosine production. Exp Dermatol 2009; 18: 306-306.
11. Gerner M, Holig K, Wehner R, Zhao S, Schakel K, Bachmann MP et al. Extracorporeal photopheresis efficiently impairs the proinflammatory capacity of human 6-sulfo LacNAc dendritic cells. Transplantation 2009; 87: 1134-1139.
12. Gorgun G, Miller KB, Foss FM. Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease. Blood 2002; 100: 941-947.
13. Goussetis E, Varela I, Tsirigotis P. Update on the mechanism of action and on clinical efficacy of extracorporeal photopheresis in the treatment of acute and chronic graft versus host disease in children. Transfus Apheresis Sci 2012; 46: 203-209.
14. Lamioni A, Parisi F, Isacchi G, Giorda E, Di Cesare S, Landolfo A et al. The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo. Transplantation 2005; 79: 846-850.
15. Kuzmina Z, Greinix HT, Knobler R, Worel N, Kouba M, Weigl R et al. Proportions of immature CD19+CD21- B lymphocytes predict the response to extracorporeal photopheresis in patients with chronic graft-versus-host disease. Blood 2009; 114: 744-746.
16. Whittle R, Taylor PC. Circulating B-cell activating factor level predicts clinical response of chronic graft-versus-host disease to extracorporeal photopheresis. Blood 2011; 118: 6446-6449.
17. Xia CQ, Campbell KA, Clare-Salzler MJ. Extracorporeal photopheresis-induced immune tolerance: a focus on modulation of antigen-presenting cells and induction of regulatory T cells by apoptotic cells. Current Opin Organ Transplant 2009; 14: 338-343.
18. Dumitru CA, Moses K, Trellakis S, Lang S, Brandau S. Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology. Cancer Immunol Immun 2012; 61: 1155-1167.
19. Youn JI, Gabrilovich DI. The biology of myeloid-derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity. Eur J Immunol 2010; 40: 2969-2975.
20. Mantovani A. The growing diversity and spectrum of action of myeloid-derived suppressor cells. Eur J Immunol 2010; 40: 3317-3320.
21. Highfill SL, Rodriguez P, Zhou Q, Goetz CA, Veenstra R, Taylor PA et al. Bone marrow myeloid-derived suppressor cells (MDSC) inhibit graft versus host disease (GVHD) via an Arginase-1 dependant mechanism that is upregulated by IL-13. Blood 2010; 116: 111-112.
22. Capitini CM, Davis JP, Larabee SM, Herby S, Nasholm NM, Fry TJ. Extracorporeal photopheresis attenuates murine graft-versus-host disease via bone marrowderived interleukin-10 and preserves responses to dendritic cell vaccination. Biol Blood Marrow Transplant 2011; 17: 790-799.
23. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304.
24. Lee SE, Cho BS, Kim JH, Yoon JH, Shin SH, Yahng SA et al. Risk and prognostic factors for acute GVHD based on NIH consensus criteria. Bone Marrow Transplant 2013; 48: 587-592.
25. Vigorito AC, Campregher PV, Storer BE, Carpenter PA, Moravec CK, Kiem HP et al. Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD. Blood 2009; 114: 702-708.
26. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945-956.
27. Bisaccia E, Vonderheid EC, Geskin L. Safety of a new, single, integrated, closed photopheresis system in patients with cutaneous T-cell lymphoma. Br J Dermatol 2009; 161: 167-169.
28. Brandau S, Trellakis S, Dumitru CA, Bruderek K, Lang S. Neutrophils in head and neck cancer: identification of putative immature neutrophilic myeloid-derived suppressor cells in the peripheral blood and pathophysiological relevance of intratumoral granulocytes. Eur J Clin Invest 2011; 41: 36-36.
29. Rieber N, Brand A, Hector A, Graepler-Mainka U, Ost M, Schafer I et al. Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease. J Immunol 2013; 190: 1276-1284.
30. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9: 162-174.
31. Merlin E, Goncalves-Mendes N, Hannani D, de la Torre A, Farges MC, Laroye H et al. Extracorporeal photochemotherapy induces arginase 1 in patients with graft versus host disease. Transplant Immunol 2011; 24: 100-106.
32. Di Biaso I, Di Maio L, Bugarin C, Gaipa G, Dander E, Balduzzi A et al. Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells. Transplantation 2009; 87: 1422-1425.
33. Biagi E, Di Biaso I, Leoni V, Gaipa G, Rossi V, Bugarin C et al. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+ CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. Transplantation 2007; 84: 31-39.
34. Dani T, Knobler R. Extracorporeal photoimmunotherapy-photopheresis. Front Biosci 2009; 14: 4769-4777.
35. Oliven A, Shechter Y. Extracorporeal photopheresis: a review. Blood Rev 2001; 15: 103-108.
36. Scarisbrick J. Extracorporeal photopheresis: what is it and when should it be used? Clin Exp Dermatol 2009; 34: 757-760.
37. Ward DM. Extracorporeal photopheresis: how, when, and why. J Clin Apheresis 2011; 26: 276-285.
38. Rodriguez PC, Ernstoff MS, Hernandez CP, Atkins M, Zabaleta J, Sierra RA et al. Arginase I producing myeloid derived suppressor cells (MDSC) in renal cell carcinoma are a sub population of activated granulocytes. J Immunother 2008; 31: 931-931.
39. Youn JI, Collazo M, Shalova IN, Biswas SK, Gabrilovich DI. Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. J Leukoc Biol 2012; 91: 167-181.
40. Liu Z, Lu Y, Lebwohl M, Wei H. PUVA (8-methoxy-psoralen plus ultraviolet A) induces the formation of 8-hydroxy-2'-deoxyguanosine and DNA fragmentation in calf thymus DNA and human epidermoid carcinoma cells. Free Radic Biol Med 1999; 27: 127-133.
41. Sander LE, Sackett SD, Dierssen U, Beraza N, Linke RP, Muller M et al. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J Exp Med 2010; 207: 1453-1464.
42. Sakaguchi S, Vignali DAA, Rudensky AY, Niec RE, Waldmann H. The plasticity and stability of regulatory T cells. Nat Rev Immunol 2013; 13: 461-467.
43. Centuori SM, Trad M, LaCasse CJ, Alizadeh D, Larmonier CB, Hanke NT et al. Myeloid-derived suppressor cells from tumor-bearing mice impair TGF-beta-induced differentiation of CD4+CD25+FoxP3+ Tregs from CD4+ CD25-FoxP3- T cells. J Leukoc Biol 2012; 92: 987-997.